Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India

The purpose of study to assess the control of dyslipidemia in the Indian diabetic population treated with any hypolipidemic agent.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dyslipidemia Diabetes Mellitus Diabetes Mellitus, Type 2 Dyslipidemias Endocrine System Diseases Glucose Metabolism Disorders Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Type 2 Diabetes Mellitus

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult who is a known Type 2 diabetic as per the ADA 2010 criteria OR controlled diabetic (taking any antidiabetic medication)
Patients in the study will have been on lipid lowering drugs at a stable dose for the last three months before the designated study visit.

Exclusion criteria

Type 1 diabetic patients
Patients with a history of hepatic or renal diseases
Hypertension due to organic diseases

Treatment and study plan

Primary outcomes

Proportion of type 2 diabetic dyslipidemia patients achieving the target LDL goal according to ADA 2010. These patients should be on stable dose of Lipid Lowering Drugs(LDL) for at least 3 months

Secondary outcomes

Proportion of dyslipidemia control rate according to american diabetes Association (ADA) 2010 criteria by age and gender
Control of dyslipidemia by Lipid Lowering Drugs (LLDs) drugs alone or combination
Control of dyslipidemia by all commercial available brands hypolipidemics drugs

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

A Non Interventional, Cross Sectional, Epidemiological Study on the Management of Dyslipidemia in Type 2 DM Adult Patients in India

Acronym: SOLID

Important dates

Study start: 2011
Study completion: 2012
First posted: Feb 9, 2011
Registry last updated: Feb 21, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed